DNDI-8219

N/A

Report date: 2023/03/19 13:26:37
NME

Base Information

Drug NameDNDI-8219
Drug Alias NameDNDI-8219
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated potassium channel subunit Kv11.1 inhibitors
TargetsVoltage-gated potassium channel subunit Kv11.1
Therapy Area/IndicationsLeishmaniasis, Visceral
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Auckland
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Auckland
Inactive CompaniesN/A
Active IndicationsLeishmaniasis, Visceral
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A